Black Diamond Therapeutics Inc at TD Cowen Healthcare Conference Transcript
Okay, welcome back to the 46th Annual TD Cowen Healthcare Conference. Marc Frahm from the biotech team here at TD Cowen, and we're really happy to have with us for the next session here, Black Diamond Therapeutics and CEO, Mark Valleca.
So the way this session's going to work is Mark's going to run through some slides, kind of general overview, level set people who may not be quite in the weeds on the story yet, and then I'll be back and we'll do some Q&A with the remaining time. And people in the room are welcome to join if you have your own questions. I want to get it -- that we want to get those answered for you as well.
With that, I'll turn it over to Mark.
Great. Thanks, Marc, and the whole TD Cowen team for the opportunity to present the Black Diamond story today.
This is to remind you that I will be making forward-looking statements.
So Black Diamond is a clinical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
